As of 2025-06-30, the Relative Valuation of Pulse Biosciences Inc (PLSE) is (32.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.08 USD, the upside of Pulse Biosciences Inc based on Relative Valuation is -317.5%.
The range of the Relative Valuation is (31.85) - (33.39) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.6x - 44.5x | 38.4x |
| Forward P/E multiples | 34.2x - 37.3x | 34.8x |
| Fair Price | (31.85) - (33.39) | (32.80) |
| Upside | -311.2% - -321.4% | -317.5% |
| Date | P/E |
| 2025-06-26 | -16.63 |
| 2025-06-25 | -17.10 |
| 2025-06-24 | -17.20 |
| 2025-06-23 | -17.30 |
| 2025-06-20 | -17.08 |
| 2025-06-18 | -16.81 |
| 2025-06-17 | -16.79 |
| 2025-06-16 | -17.12 |
| 2025-06-13 | -17.61 |
| 2025-06-12 | -18.07 |
| 2025-06-11 | -18.68 |
| 2025-06-10 | -19.36 |
| 2025-06-09 | -19.31 |
| 2025-06-06 | -19.09 |
| 2025-06-05 | -18.22 |
| 2025-06-04 | -19.60 |
| 2025-06-03 | -19.69 |
| 2025-06-02 | -18.85 |
| 2025-05-30 | -19.32 |
| 2025-05-29 | -19.92 |
| 2025-05-28 | -20.02 |
| 2025-05-27 | -18.90 |
| 2025-05-23 | -18.86 |
| 2025-05-22 | -18.83 |
| 2025-05-21 | -19.32 |
| 2025-05-20 | -19.06 |
| 2025-05-19 | -19.13 |
| 2025-05-16 | -19.20 |
| 2025-05-15 | -18.41 |
| 2025-05-14 | -18.20 |
| 2025-05-13 | -18.80 |
| 2025-05-12 | -18.75 |
| 2025-05-09 | -19.06 |
| 2025-05-08 | -18.82 |
| 2025-05-07 | -18.64 |
| 2025-05-06 | -18.48 |
| 2025-05-05 | -18.53 |
| 2025-05-02 | -19.20 |
| 2025-05-01 | -19.17 |
| 2025-04-30 | -19.01 |
| 2025-04-29 | -19.88 |
| 2025-04-28 | -20.04 |
| 2025-04-25 | -20.00 |
| 2025-04-24 | -21.52 |
| 2025-04-23 | -20.30 |
| 2025-04-22 | -20.40 |
| 2025-04-21 | -19.31 |
| 2025-04-17 | -19.81 |
| 2025-04-16 | -18.86 |
| 2025-04-15 | -19.02 |